Type 2 diabetes has prothrombotic effects

1
Type 2 diabetes has
pro-thrombotic effects
Platelet aggregability
Procoagulants (fibrinogen, von Willebrand factor,
thrombin)
Anticoagulants (antithrombin III)
2
Conclusions

• Attenuation of platelet hyperreactivity by rHDL
  is probably mediated by reduction in the
  cholesterol content of platelet membranes
• rHDL may therefore have potential in reducing
  atherothrombotic complications in type 2 diabetes